Market Research Logo

Dr. Reddy's Laboratories Ltd (DRREDDY) - Financial and Strategic SWOT Analysis Review

Section 1 - About the Company 6
Dr. Reddy's Laboratories Ltd - Key Facts 6
Dr. Reddy's Laboratories Ltd - Key Employees 7
Dr. Reddy's Laboratories Ltd - Key Employee Biographies 8
Dr. Reddy's Laboratories Ltd - Major Products and Services 9
Dr. Reddy's Laboratories Ltd - History 10
Dr. Reddy's Laboratories Ltd - Company Statement 11
Dr. Reddy's Laboratories Ltd - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Joint Venture 15
Section 2 – Company Analysis 16
Dr. Reddy's Laboratories Ltd - Business Description 16
Dr. Reddy's Laboratories Ltd - Corporate Strategy 18
Dr. Reddy's Laboratories Ltd - SWOT Analysis 19
SWOT Analysis - Overview 19
Dr. Reddy's Laboratories Ltd - Strengths 19
Dr. Reddy's Laboratories Ltd - Weaknesses 20
Dr. Reddy's Laboratories Ltd - Opportunities 21
Dr. Reddy's Laboratories Ltd - Threats 22
Dr. Reddy's Laboratories Ltd - Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios - Interim Ratios 29
Financial Ratios - Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
Dr. Reddy's Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31
Dr. Reddy's Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32
Dr. Reddy's Laboratories Ltd, Recent Deals Summary 33
Section 5 – Company’s Recent Developments 34
Jul 27, 2017: Dr. Reddy’s Q1 FY18 Financial Results 34
Jul 21, 2017: Dr. Reddy's Laboratories: Update On US FDA Audit at API Cuernavaca Plant 35
Jun 16, 2017: Dr. Reddy's Laboratories: Update on USFDA Audit 36
Jun 14, 2017: Dr. Reddy's Provides Update on API manufacturing plant at Miryalaguda 37
May 25, 2017: Dr. Reddy's Laboratories Provides Update on Srikakulum Plant 38
May 18, 2017: GE Healthcare’s FlexFactory to power Dr. Reddy’s biosimilar expansion plans 39
May 12, 2017: Dr. Reddy’s Q4 and FY17 Financial Results 41
Apr 28, 2017: Dr. Reddy's Provides Update On US FDA Audit At Bachupally Plant 43
Apr 14, 2017: Dr. Reddy’s Provides Update on USFDA Audit 44
Apr 03, 2017: Dr. Reddy's Laboratories Provides Update on USFDA Inspection at Srikakulam plant 45
Section 6 – Appendix 46
Methodology 46
Ratio Definitions 46
About GlobalData 50
Contact Us 50
Disclaimer 50
List of Tables
Dr. Reddy's Laboratories Ltd, Key Facts 6
Dr. Reddy's Laboratories Ltd, Key Employees 7
Dr. Reddy's Laboratories Ltd, Key Employee Biographies 8
Dr. Reddy's Laboratories Ltd, Major Products and Services 9
Dr. Reddy's Laboratories Ltd, History 10
Dr. Reddy's Laboratories Ltd, Subsidiaries 13
Dr. Reddy's Laboratories Ltd, Joint Venture 15
Dr. Reddy's Laboratories Ltd, Key Competitors 23
Dr. Reddy's Laboratories Ltd, Ratios based on current share price 24
Dr. Reddy's Laboratories Ltd, Annual Ratios 25
Dr. Reddy's Laboratories Ltd, Annual Ratios (Cont...1) 26
Dr. Reddy's Laboratories Ltd, Annual Ratios (Cont...2) 27
Dr. Reddy's Laboratories Ltd, Interim Ratios 29
Dr. Reddy's Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31
Dr. Reddy's Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32
Dr. Reddy's Laboratories Ltd, Recent Deals Summary 33
Currency Codes 46
Capital Market Ratios 46
Equity Ratios 47
Profitability Ratios 47
Cost Ratios 48
Liquidity Ratios 48
Leverage Ratios 49
Efficiency Ratios 49
List of Figures
Dr. Reddy's Laboratories Ltd, Performance Chart (2013 - 2017) 28
Dr. Reddy's Laboratories Ltd, Ratio Charts 30
Dr. Reddy's Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31
Dr. Reddy's Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 32

Dr. Reddy's Laboratories Ltd (DRREDDY) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Dr. Reddy's Laboratories Ltd (Dr. Reddy's) is a pharmaceutical company which manufactures and markets generic formulations, active pharmaceutical ingredients, biosimilars and proprietary products. The company’s generic products are used for the treatment of conditions such as gastrointestinal disorders, oncology, cardiovascular diseases, pain management, Central Nervous System, cancer, pain, infectious diseases and pediatrics. The company provides more than 150 products. The company also develops generic biosimilar products and has four products in the market. The company also discovers, develops, manufactures and markets New Chemical Entities (NCEs) focusing on bacterial infections, metabolic disorders, pain and inflammation. The company markets products in over 75 countries in the US, Europe, Latin America and Asia. Dr. Reddy's is headquartered in Hyderabad, Telangana, India.

Dr. Reddy's Laboratories Ltd Key Recent Developments

Jul 27,2017: Dr. Reddy’s Q1 FY18 Financial Results
Jul 21,2017: Dr. Reddy's Laboratories: Update On US FDA Audit at API Cuernavaca Plant
Jun 16,2017: Dr. Reddy's Laboratories: Update on USFDA Audit
Jun 14,2017: Dr. Reddy's Provides Update on API manufacturing plant at Miryalaguda
May 25,2017: Dr. Reddy's Laboratories Provides Update on Srikakulum Plant

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;